Literature DB >> 2055901

Outcome and clinical course in inpatient bulimic women: a 2- to 9-year follow-up study.

B A Fallon1, B T Walsh, C Sadik, J B Saoud, V Lukasik.   

Abstract

BACKGROUND: One previous follow-up study suggested that inpatient bulimic women do quite poorly; after an interval of 2 to 5 years, only 13% were recovered. To examine the course and outcome of a sample of patients with bulimia nervosa that was severe enough to require inpatient hospitalization, the authors conducted the following study.
METHOD: Women (N = 52) with DSM-III-R bulimia nervosa were sought 2 to 9 years after hospitalization. Prior to contact, a retrospective chart review was conducted to determine global functioning and admission diagnoses. At follow-up, patients participated in a 4 to 6 hour interview that assessed current and lifetime Axis I disorders (SCID-I), current Axis II disorders (PDE), eating behaviors (EAT, BSQ, EDI, PSR), global functioning (GAF), social adjustment (SAS-SR), and treatment and medical problems experienced since discharge. To assess the significance of differences between the recovered and the currently bulimic women, Yates-corrected chi-square tests and two-tailed t tests were used.
RESULTS: Of the 52 women, 46 were interviewed, 1 had died, and 5 could not be located. Of the 46 interviewed women, 39% had fully recovered, 20% had partially recovered, and 41% were currently bulimic. The likelihood of recovery increased with length of time since discharge. While medical problems related to the bulimia were few, treatment with phenelzine was associated with three reports of serious hypertensive episodes, one of which led to death. Global functioning before hospitalization, lifetime DSM-III-R Axis I diagnoses, and current Axis II diagnoses were not associated with outcome.
CONCLUSIONS: These findings suggest that even severely ill bulimic patients have a significant chance of achieving full recovery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055901

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  Borderline personality, self-harm behavior, and treatment outcome among eating disorders.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2005-11

3.  Social functioning in young people at risk for schizophrenia.

Authors:  Jacob S Ballon; Tejal Kaur; Iliana I Marks; Kristin S Cadenhead
Journal:  Psychiatry Res       Date:  2007-03-26       Impact factor: 3.222

Review 4.  Does concurrent psychopathology at presentation influence response to treatment for bulimia nervosa?

Authors:  L Bell
Journal:  Eat Weight Disord       Date:  2002-09       Impact factor: 4.652

5.  Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.